Pure Food Norway Launches New Research Project on Sulforaphane and Intestinal Health
Pure Food Norway AS is excited to announce that we have been granted a new research project titled:
“Optimizing Sulforaphane Conversion and Dose for Intestinal and Celiac-Related Health.”
This project aims to scientifically verify and optimize the formation and bioavailability of sulforaphane from our freeze-dried broccoli sprouts.
The research is carried out in collaboration with Nofima AS, one of Norway’s leading food research institutions. Together, we will investigate how much sulforaphane is actually released during digestion and at what concentrations it becomes available in the intestinal environment.
Why This Research Matters
Sulforaphane is formed from glucoraphanin when the enzyme myrosinase is activated. Although sulforaphane has been widely studied in nutritional science and biochemistry, significant knowledge gaps remain when it comes to real food products, including:
-
The actual conversion efficiency from glucoraphanin to sulforaphane during digestion
-
The stability of sulforaphane throughout gastric and intestinal phases
-
Differences between formulations (pure sprouts, broccoli + radish combinations, seed-derived extracts)
Our ambition is to establish a quantitative link between product composition and real sulforaphane formation under simulated digestive conditions. This represents an important step toward more transparent, science-based product development.
Main Objectives of the Project
The project is designed to:
-
Standardize glucoraphanin levels in freeze-dried broccoli sprouts
-
Verify conversion efficiency using a harmonized in vitro digestion model
-
Define the minimal effective dose required to reach biologically relevant intestinal concentrations
-
Build a scientific foundation for potential future clinical validation
This is a qualification-phase research project, intended to generate robust preclinical data before moving toward any potential pilot human study.
Our Commitment to Scientific Integrity
The project focuses on measuring compound stability, digestion-phase conversion, and dose–response relationships. It does not constitute a clinical trial and does not imply approved health claims.
All future communication will comply with EU Regulation (EC) No 1924/2006 on nutrition and health claims. Our goal is to contribute to transparent, evidence-based innovation in the functional food sector.
At Pure Food Norway, we believe that the future of functional foods lies in measurable quality, reproducibility, and scientific validation. This project marks an important milestone in strengthening our research-driven approach.